TransMedics(TMDX)
Search documents
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages TransMedics Group, Inc. Investors to Inquire About Securities Class Action Investigation – TMDX
ACCESSWIRE Newsroom· 2025-01-20 14:00
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages TransMedics Group, Inc. Investors to Inquire About Securities Class Action Investigation – TMDX ...
The Schall Law Firm Invites Investors With Losses To Join An Inquiry Into TransMedics Group, Inc. For Securities Fraud
ACCESSWIRE Newsroom· 2025-01-17 17:45
The Schall Law Firm Invites Investors With Losses To Join An Inquiry Into TransMedics Group, Inc. For Securities Fraud ...
TransMedics Group, Inc. (TMDX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
ACCESSWIRE Newsroom· 2025-01-17 15:00
TransMedics Group, Inc. (TMDX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation ...
TMDX Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages TransMedics Group, Inc. (NASDAQ: TMDX) Investors with Significant Losses to Contact the Firm
Prnewswire· 2025-01-17 14:30
Core Viewpoint - Kessler Topaz Meltzer & Check, LLP is investigating potential violations of federal securities laws related to TransMedics Group, Inc. following allegations of fraudulent business practices and regulatory scrutiny [1][2]. Group 1: Allegations and Investigations - Scorpion Capital issued a report alleging that TransMedics engaged in fraudulent billing schemes, off-label misuse of devices, and relied on kickbacks to drive sales [2]. - The report also mentioned ongoing investigations by the DOJ, IRS, and state attorney generals concerning Medicare fraud linked to organ acquisition costs [2]. - Customer dissatisfaction was highlighted, with reports of prominent transplant centers discontinuing the use of TransMedics' devices due to concerns over their clinical value [2]. Group 2: Market Reaction - Following the allegations and report, TransMedics' stock price has decreased by more than 13% over multiple trading days [3].
Why TransMedics Fell 15.7% This Week
The Motley Fool· 2025-01-17 14:22
Shares of organ transplant innovator TransMedics Group (TMDX -4.00%) fell 15.7% through Thursday trading, according to data from S&P Global Market Intelligence.TransMedics was the target of an activist short-seller late last week, and on Monday of this week, the company responded to the accusations at an industry health conference.While the stock initially bounced back a bit after the conference, it continued to fall through the week, as investors still appear to be skittish over the controversy.Scorpion at ...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of TransMedics Group, Inc. - TMDX
ACCESSWIRE Newsroom· 2025-01-16 23:00
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of TransMedics Group, Inc. - TMDX ...
TransMedics Group, Inc. Is Being Investigated For Securities Law Violations And Affected Shareholders Are Urged To Contact The Schall Law Firm
ACCESSWIRE Newsroom· 2025-01-16 16:00
TransMedics Group, Inc. Is Being Investigated For Securities Law Violations And Affected Shareholders Are Urged To Contact The Schall Law Firm ...
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against TransMedics Group, Inc. (TMDX) and Encourages Stockholders to Learn More About the Investigation
ACCESSWIRE Newsroom· 2025-01-16 15:00
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against TransMedics Group, Inc. (TMDX) and Encourages Stockholders to Learn More About the Investigation ...
TRANSMEDICS ALERT: Bragar Eagel & Squire, P.C. is Investigating TransMedics Group, Inc. on Behalf of TransMedics Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire News Room· 2025-01-16 02:00
NEW YORK, Jan. 15, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against TransMedics Group, Inc. (“TransMedics” or the “Company”) (NASDAQ:TMDX) on behalf of TransMedics stockholders. Our investigation concerns whether TransMedics has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in the action. The investigation focuses on whether the Company iss ...
TMDX Investor News: Rosen Law Firm Encourages TransMedics Group, Inc. Investors to Inquire About Securities Class Action Investigation - TMDX
Prnewswire· 2025-01-15 02:13
NEW YORK, Jan. 14, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of TransMedics Group, Inc. (NASDAQ: TMDX) resulting from allegations that TransMedics may have issued materially misleading business information to the investing public.So What: If you purchased TransMedics securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee a ...